New application in the RIM suite to unify publishing capabilities and content management,
from planning through archival, within a single cloud platform
Pleasanton, CA - Veeva Systems today announced Veeva Vault Submissions Publishing, a new cloud application that seamlessly incorporates publishing capabilities within Veeva Vault RIM to speed regulatory submission delivery. The addition of Vault Submissions Publishing unifies publishing capabilities and enterprise content management to streamline end-to-end submission development. Now life sciences companies can plan, review, publish, archive, and validate submissions within a single cloud platform.
Traditionally, regulatory submissions are created with disparate systems for content management and publishing. Working with separate systems requires file transfers and impedes the publishing team’s visibility into document readiness, making it difficult to effectively plan and allocate resources.
“Submission planning, registration tracking, document management, and publishing are all within one end-to-end process,” said Steve Gens, managing partner at Gens and Associates. “Having publishing within a set of unified regulatory capabilities can reduce cycle times and improve productivity throughout the entire submission development process.”
Veeva Vault Submissions Publishing empowers publishing teams to perform activities during document authoring, formatting, and reviews. This enables a continuous publishing process instead of waiting for the submission plan and documents to be finalized. With activities such as document hyperlinking and validation now moved upstream and automated, teams can complete work faster and speed submission development.
“The industry struggles with disjointed systems that force regulatory teams to duplicate data, documents, and effort,” said Frank Bosley, vice president, global head of regulatory operations at The Medicines Company. “A unified RIM approach like Veeva's can streamline submission preparation and enable sponsors to reduce risk and delays.”
Veeva Vault Submissions Publishing together with Vault Registrations, Vault Submissions, and Vault Submissions Archive delivers a unified RIM suite for seamless information and traceability throughout RIM processes.
“RIM transformation is gaining considerable momentum as companies seek greater visibility and global alignment across regulatory,” said John Lawrie, vice president, Veeva Vault RIM, at Veeva. “Now, with end-to-end submission development, regulatory can speed submission delivery and gain complete traceability between source documents, filed dossiers, and related product registrations.”
Veeva Vault Submissions Publishing is planned for availability in early 2018.
Additional Information
For more on Veeva Vault Submissions Publishing: veeva.com/Publishing
For more on Veeva Vault RIM: veeva.com/RIM
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystemsAbout Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 475 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit veeva.com.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.